- Home
- CINT vs NAGE Comparison
CINT vs NAGE Comparison
Compare CINT & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CINT
- NAGE
- Stock Information
- Founded
- CINT 1995
- NAGE 1999
- Country
- CINT Brazil
- NAGE United States
- Employees
- CINT N/A
- NAGE N/A
- Industry
- CINT EDP Services
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- CINT Technology
- NAGE Health Care
- Exchange
- CINT Nasdaq
- NAGE Nasdaq
- Market Cap
- CINT 670.2M
- NAGE 766.4M
- IPO Year
- CINT 2021
- NAGE N/A
- Fundamental
- Price
- CINT $4.48
- NAGE $7.34
- Analyst Decision
- CINT Strong Buy
- NAGE Strong Buy
- Analyst Count
- CINT 4
- NAGE 3
- Target Price
- CINT $7.20
- NAGE $17.00
- AVG Volume (30 Days)
- CINT 404.4K
- NAGE 1.2M
- Earning Date
- CINT 11-13-2025
- NAGE 10-30-2025
- Dividend Yield
- CINT N/A
- NAGE N/A
- EPS Growth
- CINT 34.66
- NAGE N/A
- EPS
- CINT 0.25
- NAGE 0.22
- Revenue
- CINT $452,826,000.00
- NAGE $116,303,000.00
- Revenue This Year
- CINT $12.12
- NAGE $28.91
- Revenue Next Year
- CINT $12.92
- NAGE $20.89
- P/E Ratio
- CINT $18.22
- NAGE $34.52
- Revenue Growth
- CINT 1.02
- NAGE 35.90
- 52 Week Low
- CINT $4.42
- NAGE $3.18
- 52 Week High
- CINT $8.00
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- CINT 29.07
- NAGE 33.70
- Support Level
- CINT $4.43
- NAGE $7.00
- Resistance Level
- CINT $5.05
- NAGE $7.60
- Average True Range (ATR)
- CINT 0.24
- NAGE 0.55
- MACD
- CINT -0.09
- NAGE -0.21
- Stochastic Oscillator
- CINT 5.60
- NAGE 15.41
About CINT CI&T Inc
CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.